Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

CONTEXT. The oncolytic polio-rhinovirus recombinant (PVSRIPO) has demonstrated promise in currently ongoing phase I/II clinical trials against recurrent glioblastoma and was granted breakthrough therapy designation by the Food and Drug Administration/Center for Biologics Evaluation and Research. A r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arch Pathol Lab Med
Egile Nagusiak: Chandramohan, Vidyalakshmi, Bryant, Jeffrey D., Piao, Hailan, Keir, Stephen T., Lipp, Eric S., Lefaivre, Michaela, Perkinson, Kathryn, Bigner, Darell D., Gromeier, Matthias, McLendon, Roger E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6051547/
https://ncbi.nlm.nih.gov/pubmed/28829151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5858/arpa.2016-0580-OA
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak